Black women with Lyme disease face significant disparities in diagnosis and treatment compared to their white counterparts, according to research highlighted in “Disparities in Lyme Disease Diagnosis, Outcomes Affect Black Patients” published on RheumatologyAdvisor.com. [1]
The article cites a study by researchers at Johns Hopkins University that found Black patients, particularly women, were more likely to experience delays in Lyme disease diagnosis and receive inadequate antibiotic treatment. Dr. Yvette Brutsch, an artist and activist featured in the piece, recounted her struggle with debilitating symptoms that went undiagnosed for years due to dismissals from medical professionals.
Another study from the University of Pennsylvania revealed Black patients were significantly underrepresented in Lyme disease research and clinical trials, despite higher rates of the disease in certain regions with large Black populations. This lack of representation can perpetuate disparities in understanding how Lyme manifests and progresses in different racial groups.
The disparities underscore the need for increased awareness, education, and inclusive research to ensure equitable diagnosis and care for all patients affected by Lyme disease, regardless of race or ethnicity. Addressing these issues is crucial for improving outcomes and reducing the disproportionate burden on marginalized communities.
See “Disparities in Lyme Disease Diagnosis and Outcomes Disproportionately Affect Black Patients” (May 17, 2024)
